Your search for evid returned 37 results

Benzbromarone, a urate-lowering drug, appeared effective among patients with high serum uric acid levels who had no evidence of gout flares.

The increasing number of indications for second-generation antiandrogens may result in a large group of men at risk for toxic effects.

Reviewers discussed new and conventional therapies for lupus nephritis and the prospect of precision medicine.

5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.

Most men with localized prostate cancer do not die within 15 years, whether or not they receive active surveillance or treatment.

Patients with advanced CKD have not been well-represented in trials evaluating intensive blood pressure control.

The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.

Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.

The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.

Statin use in prostate cancer is attractive given their proven cardiovascular benefits and favorable toxicity profile, according to investigators.